Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
NACompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
September 30, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Conditions
Breast Cancer
Interventions
DRUG
Doxorubicin, Docetaxel, Cisplatin
Doxorubicin, Docetaxel, Cisplatin
All Listed Sponsors
lead
King Faisal Specialist Hospital & Research Center
OTHER
NCT00538525 - Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter